Guzha, BTNgxola, NAdams, TRogers, LMbatani, NWu, H-TFakie, NMuzenda, VDenny, LA2024-10-022024-10-022018-8-2Guzha BT, Ngxola N, Adams T, Rogers L, Mbatani N, Wu HT, Fakie N, Muzenda V, Denny LA. Synchronous oligometastases in cervical cancer: a case report. Southern African Journal of Gynaecological Oncology. 2018;10(2):34-7. DOI: 10.1080/20742835.2018.1491139.10.1080/20742835.2018.1491139https://doi.org/10.1080/20742835.2018.1491139https://www.tandfonline.com/doi/full/10.1080/20742835.2018.1491139https://hdl.handle.net/11288/597692Incidence and mortality of cervical cancer in South Africa is still very high and 4-6% of women present with FIGO stage IVB disease. However, the management of oligometastatic cervical cancer is not well decribed in literature. Treatment of stage IVB cervical cancer is individualised, but it mainly involves palliative systemic chemotherapy with a median survival time of about ten months. There is a growing body of evidence showing that in women with low volume oligometastatic disease, curative doses of radiation therapy to the pelvis and metastatic sites with or without chemotherapy can prolong survival significantly. Since South Africa is one of the few countries in Africa with functional chemoradiation therapy facilities, there is a need to review this evidence and see if the standard of care has to be changed in women with oligometastatic cervical cancer.enarticle2220-105X10.1080/20742835.2018.1491139